Point72 Asia (Singapore)’s Monopar Therapeutics MNPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,761	Closed	-$64.1K	–	1117
2025 Q1	$64.1K	Buy	+1,761	New	+$64.1K	0.02%	515